|
| 38059809 | Disparities in acute myeloid leukemia treatments and outcomes. | Curr Opin Hematol | 2024 |
| 38017103 | Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). | Leukemia | 2024 |
| 36658429 | Author Correction: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. | Nat Cancer | 2023 |
| 37603350 | Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. | Blood Adv | 2023 |
| 35381077 | Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation. | Blood Adv | 2023 |
| 35708138 | Unbiased decision-making for acute myeloid leukemia still needed. | Haematologica | 2023 |
| 37058684 | Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials. | JCO Oncol Pract | 2023 |
| 37196637 | Association of social deprivation with survival in younger adult patients with AML: an Alliance study. | Blood Adv | 2023 |
| 36581735 | An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. | Nat Cancer | 2023 |
| 36823396 | Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. | Leukemia | 2023 |
| 34261293 | Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. | Haematologica | 2022 |
| 35792553 | Controlled variable selection in Weibull mixture cure models for high-dimensional data. | Stat Med | 2022 |
| 35696629 | Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention. | J Clin Oncol | 2022 |
| 35788257 | High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. | Blood Adv | 2022 |
| 35658604 | Dabrafenib Versus Dabrafenib + Trametinib in <i>BRAF</i>-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial. | Thyroid | 2022 |
| 35924979 | The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation. | Cancer Discov | 2022 |
| 36184192 | High-dimensional genomic feature selection with the ordered stereotype logit model. | Brief Bioinform | 2022 |
| 34847232 | Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia. | Blood Adv | 2022 |
| 32759975 | Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations. | Leukemia | 2021 |
| 33683341 | Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia. | Blood Adv | 2021 |
| 33761147 | Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms. | Am J Hematol | 2021 |
| 33707228 | DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. | Genome Res | 2021 |
| 33840625 | Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. | Transplant Cell Ther | 2021 |
| 34863095 | Discovery of clinically relevant fusions in pediatric cancer. | BMC Genomics | 2021 |
| 34845035 | Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes. | Proc Natl Acad Sci U S A | 2021 |
| 34826414 | Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers. | Lancet Haematol | 2021 |
| 34251414 | Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance). | Blood Adv | 2021 |
| 34229733 | Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement. | J Hematol Oncol | 2021 |
| 34162404 | A precision medicine classification for treatment of acute myeloid leukemia in older patients. | J Hematol Oncol | 2021 |
| 33277314 | Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia. | Cancer Discov | 2021 |
| 31462731 | Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21. | Leukemia | 2020 |
| 32024448 | Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in <i>APC</i>, <i>BRAF</i>, and <i>KTM2D</i>. | Thyroid | 2020 |
| 31945158 | Clinical and functional significance of circular RNAs in cytogenetically normal AML. | Blood Adv | 2020 |
| 32092139 | Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801. | Blood Adv | 2020 |
| 32974613 | Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions. | Blood Cancer Discov | 2020 |
| 33020282 | Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/<i>KMT2A</i>. | Proc Natl Acad Sci U S A | 2020 |
| 32526020 | ON TRacK towards novel targets in leukemia. | Blood | 2020 |
| 32461631 | Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia agedâ¿¿<60 years. | Leukemia | 2020 |
| 31413100 | Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia. | Haematologica | 2020 |
| 30291333 | Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA. | Leukemia | 2019 |
| 31297337 | Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study. | Front Oncol | 2019 |
| 31375516 | Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia. | Clin Cancer Res | 2019 |
| 30737482 | Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. | Leukemia | 2019 |
| 31116161 | Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy. | Melanoma Res | 2019 |
| 30679803 | Implementation of standardized variant-calling nomenclature in the age of next-generation sequencing: where do we stand? | Leukemia | 2019 |
| 29563537 | Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies. | Leukemia | 2018 |
| 29991495 | Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission. | Blood Adv | 2018 |
| 29872168 | NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. | Leukemia | 2018 |
| 27784745 | Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality. | Cancer Res | 2017 |
| 28336936 | No evidence for microsatellite instability in acute myeloid leukemia. | Leukemia | 2017 |